$1.2M Grant Awarded For Groundbreaking Prostate Cancer Research On Syndevrx Metap2 Inhibitor 'Evexomostat'
Award follows extensive pre-clinical, single agent activity data generated by Prof. Colleen Nelson's lab at QUT in 'Aggressive Variant' prostate ca ...